Literature DB >> 23633675

Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.

Xiangming Ding1, Hongya Pan, Jiong Li, Qi Zhong, Xiaohong Chen, Sarah M Dry, Cun-Yu Wang.   

Abstract

The transcription factor AP1 (activating protein 1), a heterodimer of the JUN and FOS proteins, promotes the invasive growth and metastasis of various tumors such as squamous cell carcinoma (SCC), breast cancer, and melanoma. AP1 activity is transcriptionally induced through a positive feedback loop. We identified the histone demethylase KDM4A (lysine-specific demethylase 4A) as a key epigenetic priming factor in this positive feedback loop. KDM4A contributed to the induction of genes encoding the AP1 transcription factors and the invasive growth and metastasis of SCC. KDM4A knockdown decreased the growth factor-induced messenger RNA expression and protein abundance of AP1 family members, including JUN and FOSL1. Mechanistically, histone demethylation by KDM4A facilitated the binding of the AP1 complex to the promoters of JUN and FOSL1, thereby promoting the positive feedback loop that maintains activation of AP1. In a mouse model of SCC, KDM4A knockdown inhibited lymph node metastasis. Moreover, the abundance of KDM4A correlated with the abundance of JUN and FOSL1 in human SCC tissues, and KDM4A expression was increased in human lymph node metastases. Our studies provide insights into the epigenetic control of AP1 and tumor invasion and suggest that KDM4A could be an important therapeutic target for inhibiting invasive SCC growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23633675      PMCID: PMC3951265          DOI: 10.1126/scisignal.2003884

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  37 in total

Review 1.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  An orthotopic nude mouse model of oral tongue squamous cell carcinoma.

Authors:  Jeffrey N Myers; F Christopher Holsinger; Samar A Jasser; B Nebiyou Bekele; Isaiah J Fidler
Journal:  Clin Cancer Res       Date:  2002-01       Impact factor: 12.531

3.  Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.

Authors:  Chao-Nan Qian; Xiang Guo; Brian Cao; Eric J Kort; Chong-Chou Lee; Jindong Chen; Ling-Mei Wang; Wei-Yuan Mai; Hua-Qing Min; Ming-Huang Hong; George F Vande Woude; James H Resau; Bin Tean Teh
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

4.  Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas.

Authors:  M F Di Renzo; M Olivero; T Martone; A Maffe; P Maggiora; A D Stefani; G Valente; S Giordano; G Cortesina; P M Comoglio
Journal:  Oncogene       Date:  2000-03-16       Impact factor: 9.867

5.  Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.

Authors:  G Dong; Z Chen; Z Y Li; N T Yeh; C C Bancroft; C Van Waes
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

Review 6.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

Review 7.  Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme.

Authors:  B W Ozanne; L McGarry; H J Spence; I Johnston; J Winnie; L Meagher; G Stapleton
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

8.  Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B.

Authors:  Qinghua Zeng; Shaoqiong Chen; Zongbing You; Fan Yang; Thomas E Carey; Daniel Saims; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2002-05-06       Impact factor: 5.157

9.  Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.

Authors:  G Cortesina; T Martone; E Galeazzi; M Olivero; A De Stefani; M Bussi; G Valente; P M Comoglio; M F Di Renzo
Journal:  Int J Cancer       Date:  2000-05-20       Impact factor: 7.396

10.  Hepatocyte growth factor inhibits anoikis by induction of activator protein 1-dependent cyclooxygenase-2. Implication in head and neck squamous cell carcinoma progression.

Authors:  Qinghua Zeng; Laurie K McCauley; Cun-Yu Wang
Journal:  J Biol Chem       Date:  2002-10-18       Impact factor: 5.157

View more
  51 in total

1.  Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

Authors:  Roselyne M Labbé; Andreana Holowatyj; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2013-12-01       Impact factor: 4.060

2.  Histone demethylase GASC1, a potential prognostic and predictive marker in esophageal squamous cell carcinoma.

Authors:  Ling-Ling Sun; Andreana Holowatyj; Xiu-E Xu; Jian-Yi Wu; Zhi-Yong Wu; Jin-Hui Shen; Shao-Hong Wang; En-Min Li; Zeng-Quan Yang; Li-Yan Xu
Journal:  Am J Cancer Res       Date:  2013-11-01       Impact factor: 6.166

3.  Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2.

Authors:  Cheng Chen; Maimaiti Aihemaiti; Xin Zhang; Hui Qu; Qi-Long Sun; Qing-Si He; Wen-Bin Yu
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

4.  Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma.

Authors:  Dhiraj Sikaria; Yaping N Tu; Diana A Fisler; James A Mauro; George Blanck
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-05       Impact factor: 4.553

Review 5.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

6.  Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.

Authors:  T Nakatsuka; K Tateishi; Y Kudo; K Yamamoto; H Nakagawa; H Fujiwara; R Takahashi; K Miyabayashi; Y Asaoka; Y Tanaka; H Ijichi; Y Hirata; M Otsuka; M Kato; J Sakai; M Tachibana; H Aburatani; Y Shinkai; K Koike
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

7.  High-resolution interrogation of functional elements in the noncoding genome.

Authors:  Neville E Sanjana; Jason Wright; Kaijie Zheng; Ophir Shalem; Pierre Fontanillas; Julia Joung; Christine Cheng; Aviv Regev; Feng Zhang
Journal:  Science       Date:  2016-09-30       Impact factor: 47.728

8.  KDM4A, KDM4B and KDM4C in non-small cell lung cancer.

Authors:  Ylermi Soini; Veli-Matti Kosma; Risto Pirinen
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 9.  Transcriptional control of cancer metastasis.

Authors:  Brian Ell; Yibin Kang
Journal:  Trends Cell Biol       Date:  2013-07-06       Impact factor: 20.808

10.  Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma.

Authors:  Demeng Chen; Mansi Wu; Yang Li; Insoon Chang; Quan Yuan; Mari Ekimyan-Salvo; Peng Deng; Bo Yu; Yongxin Yu; Jiaqiang Dong; John M Szymanski; Sivakumar Ramadoss; Jiong Li; Cun-Yu Wang
Journal:  Cell Stem Cell       Date:  2017-03-09       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.